Joshua Samuel Jolissaint

NPI 1407218803ActiveIndividual· Surgery, Surgical Oncology· Baltimore, MD

Surgery, Surgical Oncology in Baltimore, Maryland, trained at University of Virginia School of Medicine (class of 2016). Part D covered 28 prescriptions written in 2024, 86% of them generic. Intera Oncology, Inc was the largest of 2 companies reporting payments in 2025, $299.08 in all, mostly food and beverage.

Overview

NPI	1407218803
Status	Active
Entity type	Individual
Sole proprietor	No
NPI issued	Mar 24, 2016
Last updated in NPPES	May 27, 2025
Certified by provider	May 27, 2025

Specialties and licenses

Taxonomy	Code	License	State
Surgery, Surgical Oncology Primary	2086X0206X	D0103763	MD
Student in an Organized Health Care Education/Training Program	390200000X	—	—

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Surgical Oncology (DC); Practitioner - Surgical Oncology (MD)

Part D prescriptions in 2024

Prescriptions (claims)	28 · 28 30-day fills
Patients	26
Total drug cost	$2,673
Generic share	86% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Virginia School of Medicine
Graduation year	2016
Medicare specialty	Surgical Oncology
Secondary specialties	General Surgery
Telehealth	Offers telehealth